<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03617302</url>
  </required_header>
  <id_info>
    <org_study_id>201805720</org_study_id>
    <nct_id>NCT03617302</nct_id>
  </id_info>
  <brief_title>Inorganic Nitrate Supplementation on Cerebrovascular Aging and Arterial Stiffness Study</brief_title>
  <acronym>INCA</acronym>
  <official_title>Effects of Inorganic Nitrate Supplementation on Cerebrovascular Aging and Arterial Stiffness Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gary L. Pierce</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effect of dietary inorganic nitrate supplementation on 1) large&#xD;
      elastic artery stiffness and hemodynamics and 2) cerebrovascular function in middle-aged and&#xD;
      older adults. Participants will be randomized to consume either nitrate-containing or&#xD;
      nitrate-depleted beetroot juice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reduced nitric oxide bioavailability with aging contributes in part to increased large&#xD;
      central artery stiffness and cerebrovascular dysfunction. Large central artery stiffness is a&#xD;
      risk factor for cognitive decline mediated in part by the development of cerebrovascular&#xD;
      dysfunction. This study will investigate the degree to which improving nitric oxide&#xD;
      bioavailability using dietary inorganic nitrate supplementation improves cerebrovascular&#xD;
      function through reductions in large central artery stiffness in middle-aged and older&#xD;
      adults.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute change in carotid artery stiffness</measure>
    <time_frame>2-hours</time_frame>
    <description>Common carotid artery stiffness measured by ultrasonography and applanation tonometry.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute change in cerebral blood flow</measure>
    <time_frame>2-hours</time_frame>
    <description>Large cerebral artery blood flow will be measured using 4-Dimensional (4D) phase contrast vastly undersampled isotropic projection imaging (pcVIPR) magnetic resonance imaging (MRI).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Internal carotid artery endothelium-dependent dilation</measure>
    <time_frame>2-hours</time_frame>
    <description>Endothelium-dependent dilation of the internal carotid artery in response to hypercapnia will be measured using ultrasonography.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Aging</condition>
  <condition>Arterial Stiffness</condition>
  <condition>Endothelial Dysfunction</condition>
  <condition>Hypertension</condition>
  <condition>Cognitive Decline</condition>
  <arm_group>
    <arm_group_label>Beetroot juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10-grams of nitrate-containing beetroot concentrate diluted in 120-180 milliliters of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Beetroot juice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 grams of nitrate-depleted beetroot concentrate balanced for anti-oxidant content diluted in 120-180 milliliters of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Experimental: Nitrate-containing</intervention_name>
    <description>Experimental</description>
    <arm_group_label>Beetroot juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo: Nitrate-depleted</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo Beetroot juice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 50-79 years&#xD;
&#xD;
          -  Cognitively healthy, having mild cognitive impairment&#xD;
&#xD;
          -  Able to undergo cardiovascular testing procedures including fasting overnight and&#xD;
             holding selected morning medication doses.&#xD;
&#xD;
          -  Ability to understand and willingness to sign a written informed consent document.&#xD;
&#xD;
          -  Ability to lie comfortably for up to 90 minutes&#xD;
&#xD;
          -  Women only: Post-menopausal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or history of cardiovascular disease disease (heart attack, stroke, heart&#xD;
             failure, cardiomyopathy or peripheral artery disease, heart angioplasty/stent or&#xD;
             bypass surgery, valve replacement, carotid endarterectomy, heart transplant.&#xD;
&#xD;
          -  Medical history of stroke or other neurological disorder or systemic illness that&#xD;
             could potentially affect cognition or brain function (outside of a diagnosis of Mild&#xD;
             Cognitive impairment, Alzheimer's Disease) or could affect their safety or comfort&#xD;
             while undergoing the imaging or cardiovascular studies.&#xD;
&#xD;
          -  Subjects with evidence of cardiovascular disease at baseline or during the exercise&#xD;
             test (evidence of myocardial infarction, abnormal cardiac arrhythmia, myocardial&#xD;
             ischemia, conduction delays, &gt;1mm S-T segment depression or elevation; &gt;3 beat&#xD;
             ventricular tachycardia; atrial fibrillation) will be excluded from the study.&#xD;
&#xD;
          -  Wilson's disease, hemochromatosis&#xD;
&#xD;
          -  Individuals taking clonidine or other short-acting beta blocker&#xD;
&#xD;
          -  Resting blood pressure &gt; 200/ 110 mmHg or systolic &lt;90 mmHg&#xD;
&#xD;
          -  Medical history of chronic major psychiatric or current diagnosis of major psychiatric&#xD;
             disease (other than dementia).&#xD;
&#xD;
          -  Systemic illness or neurological disorder potentially affecting cognition or cerebral&#xD;
             blood flow other than mild cognitive impairment&#xD;
&#xD;
          -  Unable to provide informed consent due to cognitive impairment&#xD;
&#xD;
          -  Currently taking medications that may affect cerebral blood flow (e.g. papaverine,&#xD;
             indomethacin, acetazolamide, etc) or efficacy of beetroot juice (proton pump&#xD;
             inhibitors)&#xD;
&#xD;
          -  Current clinically abnormal thyroid function not adequately regulated by thyroid&#xD;
             hormone supplementation or medication.&#xD;
&#xD;
          -  Allergic to beets&#xD;
&#xD;
          -  Current tobacco user or history of tobacco use within the past 3 months (cigarettes,&#xD;
             cigars, chewing tobacco, hookah, electronic cigarettes) or living with someone who&#xD;
             smokes/has smoked in the past 3 months.&#xD;
&#xD;
          -  Current diagnosis of insulin-dependent diabetes (Type I or insulin dependent Type II)&#xD;
&#xD;
          -  Current diagnosis of chronic obstructive lung disease, cystic fibrosis, emphysema,&#xD;
             chronic bronchitis&#xD;
&#xD;
          -  History of renal failure, dialysis or kidney transplant&#xD;
&#xD;
          -  Current diagnosis or history of liver disease or HIV/AIDS, or cancer (other than&#xD;
             non-melanoma skin cancers).&#xD;
&#xD;
          -  Current diagnosis or history of rheumatoid arthritis, systemic lupus erythematosus,&#xD;
             Wegener's granulomatosis&#xD;
&#xD;
          -  Vulnerable populations (prisoners, etc) will not be eligible.&#xD;
&#xD;
          -  Unwillingness to wash out from a vitamin or dietary supplement regime prior to&#xD;
             enrollment and maintain throughout the duration of the study.&#xD;
&#xD;
          -  Inability to comply with experimental instructions.&#xD;
&#xD;
          -  Uncontrolled intercurrent illness that would limit compliance with study requirements&#xD;
             per investigator.&#xD;
&#xD;
          -  Inability to fast or hold morning medications doses until after testing is complete.&#xD;
&#xD;
          -  Hormone replacement use within the past 6 months&#xD;
&#xD;
          -  Currently enrolled in another study using an study medication, supplement, device or&#xD;
             intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Pierce, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gary L Pierce, PhD</last_name>
    <phone>(319)335-9487</phone>
    <email>gary-pierce@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy Stroud, RN</last_name>
    <phone>(319)356-2710</phone>
    <phone_ext>3193562710</phone_ext>
    <email>amy-stroud@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary L Pierce, PhD</last_name>
      <email>gary-pierce@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amy Stroud, RN</last_name>
      <phone>3193562710</phone>
      <email>amy-stroud@uiowa.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Gary L. Pierce</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Carotid artery stiffness</keyword>
  <keyword>Cerebrovascular function</keyword>
  <keyword>Cerebral blood flow</keyword>
  <keyword>Pulsatility</keyword>
  <keyword>Beetroot juice</keyword>
  <keyword>Dietary Inorganic Nitrate Supplementation</keyword>
  <keyword>Cerebral Small Vessel Disease</keyword>
  <keyword>Cerebrovascular Reserve</keyword>
  <keyword>Neurovascular Coupling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

